DRUG

ACT-1004-1239

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for ACT-1004-1239

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
CXCR7 poor overall survival 0.208 Mid novel signal none

Clinical trials

3 registered trials for ACT-1004-1239

Source: ClinicalTrials.gov

← All drugs